Triple

T6006065
Position Surface form Disambiguated ID Type / Status
Subject ICH Q10 Pharmaceutical Quality System E133712 entity
Predicate issuedBy P29 FINISHED
Object International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use E23680 NE FINISHED

Named-entity recognition

Before disambiguation, gpt-5-mini classified whether the object phrase is a named entity — the step behind the object's NE type shown above.

Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use | Statement: [ICH Q10 Pharmaceutical Quality System, issuedBy, International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use]

Disambiguation candidates (1 decision)

The exact options the model was shown at each disambiguation step, with the option it chose highlighted — the evidence behind this triple's disambiguated ids.

NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
Context triple: [ICH Q10 Pharmaceutical Quality System, issuedBy, International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use]
  • A. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use chosen
    The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
  • B. Committee for Proprietary Medicinal Products
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • C. European Federation of Pharmaceutical Industries and Associations
    The European Federation of Pharmaceutical Industries and Associations (EFPIA) is a Brussels-based trade association representing the research-based pharmaceutical industry in Europe, advocating for policies that support innovation, patient access to medicines, and a competitive life sciences sector.
  • D. Committee for Medicinal Products for Human Use
    The Committee for Medicinal Products for Human Use is the European Medicines Agency’s expert body responsible for evaluating and providing scientific opinions on the safety, quality, and efficacy of medicines for human use in the European Union.
  • E. Committee for Herbal Medicinal Products
    The Committee for Herbal Medicinal Products is a scientific body within the European Medicines Agency that evaluates and provides guidance on the safety and efficacy of herbal medicines in the European Union.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

Stage Batch ID Job type Status
creating batch_69c00872444c8190bfaf1739dcec765c elicitation completed
NER batch_69c04f128354819088971ee398cbda77 ner completed
NED1 batch_69c63849a59881909e32c0271b4beb51 ned_source_triple completed
Created at: March 22, 2026, 4:06 p.m.